The CFO Already Ran the Numbers
The CFO in your next meeting has already seen the Medicaid reconciliation numbers. They have not frozen your deal because the product is wrong. They are running scenarios before they sign off on anything new.
The Signal
On April 10, Congress cleared the procedural path for $880 billion in federal spending cuts.
That path runs through Medicaid. The House Energy and Commerce Committee has to find those savings, and there is no way to reach that number without cutting Medicaid reimbursement to hospitals. The analysis is public. Kodiak Solutions modeled the impact: the current reconciliation bill costs hospitals up to $25 billion a year in revenue.
Hospital operating margins were already at 1.9% through Q1 2026, according to Kaufman Hall's latest index. That is below the threshold most health system CFOs treat as the floor for discretionary capital deployment.
The CFO in your next meeting has already seen these numbers. They have not frozen your deal because the product is wrong. They are running three scenarios for what next year's revenue base looks like before they sign off on anything new.
The rep who calls this week and asks "what does your budget cycle look like?" is asking the wrong question in the wrong room. The room was already full before they arrived, with a $25 billion revenue risk, a 1.9% margin index, and a CFO who has been running scenario models since April 11.
That information is free. It was published in Becker's, in Kaufman Hall's public index, in the CBO's reconciliation scoring. The CFO read it. Most reps have not.
The Mechanic
Here is what the CFO needs before they approve a capital item. Not wants. Needs.
Three things, scored separately, all required: financial return (will this generate revenue, reduce cost, or reduce liability?), operational justification (does this solve a workflow problem that is already measured?), and strategic alignment (does this support a stated system priority?).
Capital requests that cannot be scored on all three go to the bottom of the ranking stack. Not declined, tabled. They wait there until someone brings the missing argument.
Most medtech reps walk into capital conversations carrying one of the three. They have the clinical data. The clinical case is strong. The clinical champion is sold. Then the deal stalls.
The stall is almost never clinical. The buyer has the clinical case. They are waiting for the financial return statement and the operational justification that clears the other two-thirds of the approval model. The clinical champion cannot provide those. They do not speak CFO. You have to.
This is what COF is: Clinical, Operational, Financial, three layers of value that correspond exactly to the three scoring criteria the capital committee uses. When you build your commercial case at all three layers, you are not being more thorough. You are handing the clinical champion the arguments they need to advocate for your deal in the meeting you are not in.
In the current environment, the financial layer matters more than it has in years. A CFO modeling $25 billion in potential Medicaid losses is not going to approve a capital item that has a strong clinical case and an unclear financial return. The clinical case earns the meeting. The financial case earns the approval.
The fear in the room right now, for the CFO, not just for you, is revenue base erosion. Fuel is a proposal that starts there, acknowledges the scenario they are running, and positions your product as a cost reduction or liability reduction argument, not a revenue generation argument. In a 1.9% margin environment, cost reduction clears the model. Revenue uplift waits.
The Move
Before your next hospital call this week, spend ten minutes on one document.
Pull the Kaufman Hall National Hospital Flash Report. It is free and public. Find out whether your account's health system is above or below the 1.9% sector average.
If they are below it: the CFO is in preservation mode. Open the financial conversation with cost reduction or liability reduction, not revenue generation. Your clinical case becomes the operational justification. Your financial case leads with what this costs them to not have.
If they are above it: they have capital room, but they are watching Medicaid developments closely. Acknowledge the environment. Show that you read the same reports they did. Then make the case.
One document. Ten minutes. Different conversation.
Dr. Gunter Wessels is the founder of LiquidSMARTS℠, a commercial engineering firm for medical technology companies. LiquidSMARTS℠ guarantees 10% pipeline velocity improvement in 90 days.